(WRB) W. R. Berkley - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0844231029

Insurance, Reinsurance, Liability, Property, Casualty

WRB EPS (Earnings per Share)

EPS (Earnings per Share) of WRB over the last years for every Quarter: "2020-09-30": 0.43, "2020-12-31": 0.61, "2021-03-31": 0.72, "2021-06-30": 0.78, "2021-09-30": 0.88, "2021-12-31": 1.02, "2022-03-31": 1.1, "2022-06-30": 1.12, "2022-09-30": 1.01, "2022-12-31": 1.16, "2023-03-31": 1, "2023-06-30": 1.14, "2023-09-30": 1.35, "2023-12-31": 1.45, "2024-03-31": 1.56, "2024-06-30": 1.04, "2024-09-30": 0.91, "2024-12-31": 1.13, "2025-03-31": 1.01, "2025-06-30": 1.05,

WRB Revenue

Revenue of WRB over the last years for every Quarter: 2020-09-30: 2039.82, 2020-12-31: 2312.471, 2021-03-31: 2156.869, 2021-06-30: 2296.086, 2021-09-30: 2424.283, 2021-12-31: 2578.228, 2022-03-31: 2915.409, 2022-06-30: 2512.887, 2022-09-30: 2724.4, 2022-12-31: 3013.802, 2023-03-31: 2895.004, 2023-06-30: 2995.914, 2023-09-30: 3030.638, 2023-12-31: 3221.382, 2024-03-31: 3256.773, 2024-06-30: 3314.032, 2024-09-30: 3400.379, 2024-12-31: 3667.568, 2025-03-31: 3547.399, 2025-06-30: 3670.808,

Description: WRB W. R. Berkley

W. R. Berkley Corp (NYSE:WRB) is a global insurance holding company with a diverse portfolio of commercial insurance products. The companys Insurance segment offers a wide range of products, including excess and surplus lines, specialty personal lines, accident and health insurance, and reinsurance products. Additionally, it provides insurance coverages for various industries, such as technology, life sciences, and travel.

The Reinsurance & Monoline Excess segment offers treaty and facultative reinsurance solutions, property and casualty reinsurance products, and turnkey products, such as cyber and employment practices liability insurance. This diversification across multiple business lines and geographies reduces the companys reliance on any single segment, making it more resilient to market fluctuations.

From a financial perspective, WRB has demonstrated strong profitability, with a Return on Equity (RoE) of 20.67%. The companys Price-to-Earnings (P/E) ratio is 16.59, indicating a relatively stable valuation. To further evaluate the companys performance, we can examine additional Key Performance Indicators (KPIs) such as the Combined Ratio, which measures the companys underwriting profitability, and the Loss Ratio, which assesses the proportion of premiums paid out in claims.

Other relevant KPIs for WRB include the companys Book Value per Share, which can help investors understand the companys underlying asset value, and the Dividend Yield, which can provide insight into the companys payout policy and shareholder returns. By analyzing these metrics, investors can gain a more comprehensive understanding of WRBs financial health and growth prospects.

Overall, W. R. Berkley Corps diversified business model, strong profitability, and stable valuation make it an attractive investment opportunity for those seeking exposure to the property and casualty insurance sector.

WRB Stock Overview

Market Cap in USD 27,999m
Sub-Industry Property & Casualty Insurance
IPO / Inception 1984-09-07

WRB Stock Ratings

Growth Rating 89.3%
Fundamental 77.7%
Dividend Rating 68.8%
Return 12m vs S&P 500 8.76%
Analyst Rating 3.56 of 5

WRB Dividends

Dividend Yield 12m 2.48%
Yield on Cost 5y 6.66%
Annual Growth 5y 46.22%
Payout Consistency 94.6%
Payout Ratio 32.7%

WRB Growth Ratios

Growth Correlation 3m 18.9%
Growth Correlation 12m 87%
Growth Correlation 5y 93.9%
CAGR 5y 20.07%
CAGR/Max DD 3y 0.76
CAGR/Mean DD 3y 3.56
Sharpe Ratio 12m 2.17
Alpha 0.04
Beta 0.766
Volatility 21.51%
Current Volume 3552.4k
Average Volume 20d 1449.9k
Stop Loss 69.2 (-3.1%)
Signal -1.12

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (1.76b TTM) > 0 and > 6% of Revenue (6% = 857.2m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA -0.42pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 274.0% (prev 233.2%; Δ 40.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 3.50b > Net Income 1.76b (YES >=105%, WARN >=100%)
Net Debt (857.3m) to EBITDA (2.34b) ratio: 0.37 <= 3.0 (WARN <= 3.5)
Current Ratio 61.72 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (400.4m) change vs 12m ago -0.83% (target <= -2.0% for YES)
Gross Margin 21.73% (prev 22.66%; Δ -0.93pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 35.03% (prev 32.96%; Δ 2.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 18.82 (EBITDA TTM 2.34b / Interest Expense TTM 127.0m) >= 6 (WARN >= 3)

Altman Z'' 7.78

(A) 0.92 = (Total Current Assets 39.78b - Total Current Liabilities 644.6m) / Total Assets 42.66b
(B) 0.30 = Retained Earnings (Balance) 12.83b / Total Assets 42.66b
(C) 0.06 = EBIT TTM 2.39b / Avg Total Assets 40.78b
(D) 0.37 = Book Value of Equity 12.42b / Total Liabilities 33.35b
Total Rating: 7.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 77.70

1. Piotroski 5.0pt = 0.0
2. FCF Yield data missing
3. FCF Margin 24.04% = 6.01
4. Debt/Equity 0.38 = 2.43
5. Debt/Ebitda 1.49 = 0.98
6. ROIC - WACC (= 8.03)% = 10.04
7. RoE 20.10% = 1.68
8. Rev. Trend 96.77% = 7.26
9. EPS Trend -13.80% = -0.69

What is the price of WRB shares?

As of September 18, 2025, the stock is trading at USD 71.42 with a total of 3,552,375 shares traded.
Over the past week, the price has changed by +1.33%, over one month by +3.70%, over three months by +1.11% and over the past year by +28.91%.

Is W. R. Berkley a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, W. R. Berkley (NYSE:WRB) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 77.70 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WRB is around 79.48 USD . This means that WRB is currently undervalued and has a potential upside of +11.29% (Margin of Safety).

Is WRB a buy, sell or hold?

W. R. Berkley has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold WRB.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 8
  • Sell: 2
  • Strong Sell: 0

What are the forecasts/targets for the WRB price?

Issuer Target Up/Down from current
Wallstreet Target Price 72.7 1.8%
Analysts Target Price 72.7 1.8%
ValueRay Target Price 88.2 23.5%

Last update: 2025-09-16 04:43

WRB Fundamental Data Overview

Market Cap USD = 28.00b (28.00b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 31.49b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.7719
P/E Forward = 15.2439
P/S = 1.9599
P/B = 3.0125
P/EG = 10.8943
Beta = 0.415
Revenue TTM = 14.29b USD
EBIT TTM = 2.39b USD
EBITDA TTM = 2.34b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 644.6m USD (from totalCurrentLiabilities, last quarter)
Debt = 3.49b USD (Calculated: Short Term 644.6m + Long Term 2.84b)
Net Debt = 857.3m USD (from netDebt column, last quarter)
Enterprise Value = 254.0k USD (28.00b + Debt 3.49b - CCE 31.49b)
Interest Coverage Ratio = 18.82 (Ebit TTM 2.39b / Interest Expense TTM 127.0m)
FCF Yield = 1.35m% (FCF TTM 3.43b / Enterprise Value 254.0k)
FCF Margin = 24.04% (FCF TTM 3.43b / Revenue TTM 14.29b)
Net Margin = 12.32% (Net Income TTM 1.76b / Revenue TTM 14.29b)
Gross Margin = 21.73% ((Revenue TTM 14.29b - Cost of Revenue TTM 11.18b) / Revenue TTM)
Tobins Q-Ratio = 0.00 (Enterprise Value 254.0k / Book Value Of Equity 12.42b)
Interest Expense / Debt = 0.91% (Interest Expense 31.8m / Debt 3.49b)
Taxrate = 22.52% (509.9m / 2.26b)
NOPAT = 1.85b (EBIT 2.39b * (1 - 22.52%))
Current Ratio = 61.72 (Total Current Assets 39.78b / Total Current Liabilities 644.6m)
Debt / Equity = 0.38 (Debt 3.49b / last Quarter total Stockholder Equity 9.29b)
Debt / EBITDA = 1.49 (Net Debt 857.3m / EBITDA 2.34b)
Debt / FCF = 1.02 (Debt 3.49b / FCF TTM 3.43b)
Total Stockholder Equity = 8.76b (last 4 quarters mean)
RoA = 4.13% (Net Income 1.76b, Total Assets 42.66b )
RoE = 20.10% (Net Income TTM 1.76b / Total Stockholder Equity 8.76b)
RoCE = 20.61% (Ebit 2.39b / (Equity 8.76b + L.T.Debt 2.84b))
RoIC = 15.97% (NOPAT 1.85b / Invested Capital 11.60b)
WACC = 7.94% (E(28.00b)/V(31.49b) * Re(8.84%)) + (D(3.49b)/V(31.49b) * Rd(0.91%) * (1-Tc(0.23)))
Shares Correlation 3-Years: -75.76 | Cagr: -0.42%
Discount Rate = 8.84% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.55% ; FCFE base≈3.38b ; Y1≈3.89b ; Y5≈5.48b
Fair Price DCF = 215.1 (DCF Value 81.58b / Shares Outstanding 379.3m; 5y FCF grow 17.79% → 3.0% )
EPS Correlation: -13.80 | EPS CAGR: 1.42% | SUE: 0.38 | # QB: 0
Revenue Correlation: 96.77 | Revenue CAGR: 11.45% | SUE: N/A | # QB: None

Additional Sources for WRB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle